Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Confavreux, S. Vukusic (2006)
Natural history of multiple sclerosis: a unifying concept.Brain : a journal of neurology, 129 Pt 3
L. Glimcher, A. Bhalla, EP Amento, B. Serog (1984)
1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.Journal of immunology, 133 4
C. Polman, S. Reingold, G. Edan, M. Filippi, H. Hartung, L. Kappos, F. Lublin, L. Metz, H. McFarland, P. O'Connor, M. Sandberg-wollheim, A. Thompson, B. Weinshenker, J. Wolinsky (2005)
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 58
T. Monkawa, Tadashi Yoshida, S. Wakino, T. Shinki, H. Anazawa, H. DeLuca, T. Suda, M. Hayashi, T. Saruta (1997)
Molecular Cloning of cDNA and Genomic DNA for Human 25-hydroxyvitamin D31α-hydroxylaseBiochemical and Biophysical Research Communications, 239
M. Sahraian, H. Pakdaman, A. Harandi (2012)
Is it time to revise the classification of geographical distribution of multiple sclerosis?Iranian Journal of Neurology, 11
Ph. Coles, F.R.C. Alastair, F.Med.Sci Compston, M. Selmaj, Sc.D Lake, M. Moran, David M.S.C.E., Kim Ph.D., B.Sc Tandon (2008)
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.The New England journal of medicine, 359 17
S. Ramagopalan, D. Dyment, M. Cader, K. Morrison, G. Disanto, J. Morahan, Antonio Berlanga-Taylor, A. Handel, G. Luca, A. Sadovnick, P. Lepage, A. Montpetit, G. Ebers (2011)
Rare variants in the CYP27B1 gene are associated with multiple sclerosisAnnals of Neurology, 70
M. Mazdeh, M. Taheri, A. Sayad, S. Bahram, M. Omrani, A. Movafagh, H. Inoko, M. Akbari, R. Noroozi, M. Hajilooi, G. Solgi (2016)
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.Pharmacogenomics, 17 5
J. Smolders, K. Schuurman, M. Strien, J. Melief, Debbie Hendrickx, E. Hol, C. Eden, S. Luchetti, I. Huitinga (2013)
Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.Journal of neuropathology and experimental neurology, 72 2
J. Sellner, J. Kraus, Amer Awad, R. Milo, B. Hemmer, O. Stüve (2011)
The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors.Autoimmunity reviews, 10 8
J. Smolders, M. Thewissen, R. Theunissen, E. Peelen, S. Knippenberg, P. Menheere, J. Tervaert, R. Hupperts, J. Damoiseaux (2011)
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosisJournal of Neuroimmunology, 235
M. Mazdeh, S. Seifirad, N. Kazemi, Mohammad Seifrabie, A. Dehghan, H. Abbasi (2013)
Comparison of vitamin D3 serum levels in new diagnosed patients with multiple sclerosis versus their healthy relatives.Acta medica Iranica, 51 5
C. Pierrot-Deseilligny, J. Souberbielle (2010)
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?Brain : a journal of neurology, 133 Pt 7
W. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. Hartung, F. Lublin, H. McFarland, D. Paty, C. Polman, S. Reingold, M. Sandberg-wollheim, W. Sibley, A. Thompson, S. Noort, B. Weinshenker, J. Wolinsky (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 50
M. Ban, S. Caillier, Inger‐Lise Mero, K. Myhr, E. Celius, J. Aarseth, Ø. Torkildsen, H. Harbo, J. Oksenberg, S. Hauser, S. Sawcer, Alastair Compston (2013)
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosisAnnals of Neurology, 73
A. Sayad, A. Allameh, A. Sayad, M. Noruzinia, M. Akbari, Ali Sarzaeem, A. Akbar, Reza Hoseini (2013)
The Association of -475 and -631 Interleukin-2 Gene Polymorphism with Multiple Sclerosis in Iranian PatientsCell Journal (Yakhteh), 15
M. Eftekharian, M. Ghannad, M. Taheri, G. Roshanaei, M. Mazdeh, M. Musavi, Mona Hormoz (2016)
Frequency of viral infections and environmental factors in multiple sclerosis.Human antibodies, 24 1-2
A. Sayad, A. Allameh, M. Noruzinia (2013)
THE INFLUENCE OF -330 IL-2 GENE POLYMORPHISM ON RELAPSING REMITTING AND SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN IRANIAN PATIENTS, 18
M. Taheri, Shirin Nemati, A. Movafagh, M. Saberi, R. Mirfakhraie, M. Eftekharian, S. Arsang-Jang, Amir Rezagholizadeh, A. Sayad (2016)
TRAIL gene expression analysis in multiple sclerosis patients.Human antibodies, 24 1-2
M. Taheri, G. Roshanaei, Jamileh Ghaffari, S. Rahimnejad, Behzad Khosroshahi, M. Aliabadi, M. Eftekharian (2017)
The effect of Base Transceiver Station waves on some immunological and hematological factors in exposed persons.Human antibodies, 25 1-2
E. Sundqvist, Maria Bäärnhielm, L. Alfredsson, J. Hillert, T. Olsson, I. Kockum (2010)
Confirmation of association between multiple sclerosis and CYP27B1European Journal of Human Genetics, 18
R. Gray, J. Omdahl, J. Ghazarian, H. DeLuca (1972)
25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties.The Journal of biological chemistry, 247 23
K. Takeyama, S. Kitanaka, Takashi Sato, M. Kobori, J. Yanagisawa, S. Kato (1997)
25-Hydroxyvitamin D3 1α-Hydroxylase and Vitamin D SynthesisScience, 277
Shima Hamedani, M. Taheri, E. Sajjadi, M. Omrani, M. Mazdeh, S. Arsang-Jang, A. Panah, A. Sayad (2017)
Up regulation of MMP9 gene expression in female patients with multiple sclerosis.Human antibodies, 24 3-4
A. Sayad (2014)
The association of −330 interleukin‐2 gene polymorphism and HLA‐DR15 allele in Iranian patients with multiple sclerosisInternational Journal of Immunogenetics, 41
Mi‐Sun Kim, R. Fujiki, H. Kitagawa, S. Kato (2007)
RETRACTED: 1α,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 geneMolecular and Cellular Endocrinology, 265
BACKGROUND: Multiple sclerosis (MS) as a complex neurologicaldisease can be due to vitamin D deficiency. CYP27B1 is referred to as avitamin D metabolizing enzyme. MATERIALS AND METHODS: This studycompared the expression level of CYP27B1 in Relapsing-Remitting MS (RRMS)patients with normal individuals in Iran. The RNA was extracted from 50 RRMSpatients and 50 normal controls. Quantitative RT-PCR was adopted to measurethe expression level of CYP27B1 gene. RESULTS: The expression levelof CYP27B1gene was significantly lower in the RRMS patients than theirnormal counterparts (P value = 0.04). Also, the RRMS females participating hada significant reduction in CYP27B1 gene expression compared to normalfemales (P-Value = 0.01). In addition, the correlation between CYP27B1expression level, and the risk of Expanded Disability Status Scaleof Kurtzke (EDSS) was not linear. Additionally, there was no significantcorrelation between expression status of CYP27B1gene and duration of thedisease. CONCLUSION: A significant decrease in the expression levelof CYP27A1 in female patients could indicate their greater vulnerability toMS than the male patients.
Human Antibodies – IOS Press
Published: Jan 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.